Briefing Room Virtual Salon Series-Policy Pressure: Communicating at the Speed of Change

Date: Wednesday, October 1
Time: 11:00AM-12:15PM (ET) including Q&A

 As policy changes reshape the future of science and innovation, the biopharma industry is under unprecedented scrutiny. From drug pricing reforms and regulatory overhauls to evolving government funding priorities, policy turbulence is driving the narratives shaping public trust, investor confidence, and industry reputation. This session of The Briefing Room brings together leading journalists and policy analysts to examine how organizations can successfully navigate and reframe conversations about innovation and stay true to mission in a continuously changing policy environment.

Listen To Recording

Spotlight Panels: A New Way to Maximize Visibility for Innovative Biotech Companies

Date: Wednesday, August 27
Time: 11:00AM-12:15PM (ET) including Q&A

This virtual salon will feature advice from investors, communication experts, and pharma BD on how to tell your story to attract funders and partners. Furthermore, this hour-long salon will introduce “Spotlight Panels” which are designed to maximize exposure for participating companies, elevate their visibility, and foster meaningful dialogue through expertly moderated, dynamic discussions with real-time audience interaction. Breaking from traditional pitch presentations, this innovative format creates richer, more memorable experiences for those seeking to discover and connect with the next wave of transformative biotech companies and technologies.

Moderator:
Lila Taylor, CBO, Demy-Colton

Panelists:
Uri Lopatin, Operating Partner, Khosla Ventures
Carolyn Ng, Partner, TPG Life Sciences Innovations
Jason Spark, Chief Biotech Officer, Inizio Evoke Communications
Chris Vlahos, Vice President, External Innovation, Acadia Pharmaceuticals

Click here to view on demand

The Science of Longevity

Date: Wednesday, June 11th, 2025
Time: 11:00AM-12:15PM (ET) including Q&A

Join Tim Opler, PhD (Stifel) and Lila Taylor (Demy-Colton) for a dynamic fireside chat on the cutting edge of longevity science. Explore how today’s biotech and pharma innovators are translating breakthroughs in genetics, cellular biology, and regenerative medicine into real-world therapies that target aging itself. Discover what’s next in lifespan/health span extension, the latest clinical advances, and the transformative impact these efforts could have on healthcare and society.

Tim Opler, Managing Director, Global Healthcare Group, Stifel
Interviewed by Lila Taylor, CBO, Demy-Colton

Aging a brief history

Click here to view on demand

CAR-T Therapies: After Seven Years, the Results are In, and the Debate Isn’t Over

Date: Wednesday, May 28th, 2025
Time: 11:00AM-12:00PM (ET)

11:00 – 11:05 am
Introduction
* Sara Demy, Founder & CEO, Demy-Colton
* Steve Brozak, DMH, President & Co-Founder, WBB Securities

11:05 – 11:10 am
Understanding the Shortcomings of CAR-T Therapy
* Helen Heslop, MD, Professor, Department of Medicine & Pediatrics and Director, Center for Cell and Gene Therapy, Baylor College of Medicine

11:10 – 11:15 am
Overcoming the Current Limitations of CAR-T Therapy
* Malcolm Brenner, MD, PhD, Professor, Center for Cell & Gene Therapy and Founding Director, Center for Cell and Gene Therapy, Baylor College of Medicine

11:15 – 11:20 am
MAR-T Cells as a Novel Approach to Address Unmet Needs
* Juan Vera, MD, President & CEO, Marker Therapeutics

11:20 – 11:50 am
Roundtable Discussion

Moderator
* Richard Marfuggi, MD, DMH, WBB Research Institute

Panelists:
* Malcolm Brenner, MD, PhD, Professor, Center for Cell & Gene Therapy and Founding Director, Center for Cell and Gene Therapy, Baylor College of Medicine
* Helen Heslop, MD, Professor, Department of Medicine & Pediatrics and Director, Center for Cell and Gene Therapy, Baylor College of Medicine
* Manali Kamdar, MD, Associate Professor of Medicine and Clinical Director of Lymphoma Services, University of Colorado
* Geoffrey Shouse, DO, PhD, Hematologist-Oncologist & Researcher, City of Hope
* Juan Vera, MD, President & CEO, Marker Therapeutics

11:50 am – 12:00 pm
Q&A

Click here to view on demand

A Conversation with Tim Opler: Navigating the Biotech Financial Markets in 2025

Join us for an insightful virtual salon, featuring Tim Opler, as we explore the evolving landscape of the biotech financial markets in 2025. As we enter a new era characterized by growth, complexity, and opportunity, the sector faces a myriad of challenges and advancements. With a new government in place, rapid technological innovations, shifting regulatory frameworks, and changing investor sentiments, understanding the future of biotech finance demands both expertise and strategic foresight.

This discussion will provide a comprehensive outlook on the biotech financial markets, offering valuable insights for investors, executives, and industry professionals. Attendees will gain a deeper understanding of the key factors shaping the market and learn how to navigate effectively in 2025 and beyond.

Tim Opler, Managing Director, Global Healthcare Group, Stifel
Interviewed by Sara Jane Demy, Founder & CEO, Demy-Colton

Listen to Recording

2025 TechBio Investor and Technology trends at Biotech Showcase During Healthcare Week

Join us for an insightful webinar featuring a panel of TechBio CEOs, venture investors, and industry experts as they discuss the latest trends and innovations shaping the future of human health during Biotech Showcase and Healthcare Week, January 13th-15th in San Francisco. This session will provide valuable updates on what to expect from the TechBio sector, including emerging technologies and investment opportunities that are set to redefine patient care, drug discovery, tools, manufacturing and digital therapeutics. Don’t miss this chance to gain expert insights and discover how the convergence of technology and biology is transforming the healthcare landscape. 

Moderator:
Lila Taylor, CBO, Demy-Colton

Panelists:
Jessica Davis, Principal, Avant Bio
Marine Mallinson, Venture Advisor, Noetic Fund
David “DSO” Suendermann-Oeft, Founder & CEO, Modality.AI
Jan Van den Berghe, Co-Founder, Novalis Fund 
Alla Zamarayeva, CEO, CellFE 

Listen to recording

The Power of Presenting at Biotech Showcase: Unlocking Investor Interest and Strategic Partnerships

 

Moderator:
Lila Taylor, CBO, Demy-Colton

Panelists:
Kimberly Ha, Founder & CEO, KKH Advisors
Barak Kassar, Co-founder, BKW Partners
Reece Kresser, Biopharma Financing & M&A, HSBC
Marian Nakada, Vice President, Venture Investments, JJDC
Ashley Zehnder, Co-founder & CEO, Fauna Bio

Listen to Recording